Filter
508
Text search:
antimicrobials
Featured
Recommendations
57
New Publications
103
Language
Document type
Studies & Reports
154
No document type
123
Guidelines
115
Strategic & Response Plan
31
Fact sheets
31
Manuals
25
Training Material
8
Situation Updates
5
Brochures
4
Resource Platforms
4
Online Courses
4
Infographics
3
Videos
1
Countries / Regions
India
27
Kenya
19
South Africa
19
Ethiopia
17
Global
11
Sierra Leone
9
Nigeria
9
Africa
9
Ghana
7
Philippines
6
Nepal
5
Latin America and the Carribbean
5
Western and Central Europe
5
Zimbabwe
4
Tanzania
4
Malawi
4
South–East Asia Region
4
Burkina Faso
3
Uganda
3
Thailand
3
Liberia
2
Senegal
2
Mali
2
Cameroon
2
Haiti
2
Pakistan
2
Jordan
2
Zambia
2
Rwanda
2
Namibia
2
East and Southern Africa
2
West and Central Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Laos
2
Tajikistan
2
Guinea
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Niger
1
Iraq
1
Afghanistan
1
Lebanon
1
Cambodia
1
China
1
Indonesia
1
Bangladesh
1
Sudan
1
Benin
1
Argentina
1
Peru
1
Eswatini/ Swaziland
1
Brazil
1
North Macedonia
1
Serbia
1
Colombia
1
Honduras
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Sri Lanka
1
Asia
1
Fiji
1
Bhutan
1
Venezuela
1
Eastern Europe
1
Albania
1
Armenia
1
Congo-Brazzaville
1
Russia
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
125
Clinical Guidelines
39
Women & Child Health
18
Key Resources
15
Public Health
9
Capacity Building
6
Pharmacy & Technologies
6
Toolboxes
AMR
292
Planetary Health
36
Rapid Response
21
COVID-19
19
Pharmacy
19
Caregiver
13
HIV
10
TB
10
Global Health Education
8
NTDs
7
Ebola
5
Cholera
3
Specific Hazards
3
Disability
2
Refugee
2
Mental Health
2
Conflict
1
Health Financing Toolbox
1
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out
...
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action
...
Information note of the Global Leaders Group on Antimicrobial Resistance.
Available in English, French, Spanish, Russian, Chinese and Arabic
A One Health Response. A Briefing Note
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries. The report provides a description of practices, how they were implemented, achievements, and why the practice was unique.
Antimicrobial resistance (AMR) has emerged as a major public health concern, around which the international leadership has come together to form strategic partnerships and action plans. The main driving force behind the emergence of AMR is selection pressure created due to consumption of antibiotics
...
PlosOne https://doi.org/10.1371/journal.pone.0161576; Zoonotic diseases have varying public health burden and socio-economic impact across time and geographical settings making their prioritization for prevention and control important at the national level. We conducted systematic prioritization of
...
Proc Natl Acad Sci U S A v.110(21); 2013 May 21 PMC3666729 ;
A systematic review was conducted by a multidisciplinary team to analyze qualitatively best available scientific evidence on the effect of agricultural intensification and environmental changes on the risk of zoonoses for which there are
...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are
...
Surveillance of antimicrobial resistance in Europe 2020 data: executive summary
The climate crisis has many consequences – among them widespread health impacts that will lead to immense societal, ecological, and economic harm.
Over the past two decades multiple large-scale reviews on climate change and health have made clear the need for a multi-sectoral approach to target t
...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
Together for One Health. Building on the momentum of increased collaboration, the WHO, FAO, OIE and UNEP have developed a Strategic Framework for collaboration on antimicrobial resistance (AMR). This Framework reflects the joint work of the four organizations to advance a One Health response to AMR
...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
Environmental pollution, protection, quality and sustainability
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re
...
